The Global Market for Biopharmaceutical Bioseparation Systems is Projected to Reach US$7.8 Billion by 2020

Growing Market for Biological Drugs Drives Growth of Biopharmaceutical Bioseparation Systems, According to a New Report by Global Industry Analysts, Inc.

GIA launches comprehensive analysis of industry segments, trends, growth drivers, market share, size and demand forecasts on the global Biopharmaceutical Bioseparation Systems market. The global market for Biopharmaceutical Bioseparation Systems is projected to reach US$7.8 billion by 2020, driven by the growing demand for biological drugs, increasing research and production of biosimilars, growing focus on enhancing efficiencies in biopharmaceutical downstream processing, and technological advancements.

Bioseparation involves separation of a biomolecule from a complex mixture of various biomolecules. In the area of biopharmaceuticals, bioseparation involves purification of biological products by employing scientific and engineering principles on a large-scale with an aim to obtain cells, cell parts and molecules in purified fractions for production of biological drugs. Also called downstream processing in manufacture of biological products, bioprocessing represents an expensive, complex and time-consuming stage in production of biological products such as biopharmaceuticals. The process of purifying biological molecules leads to enrichment of individual molecules, cells and cell parts, forming purified fractions, which carry significantly high value. Increasing demand for biopharmaceuticals is the major factor driving growth of biopharmaceutical bioseparation systems. Emergence of new biological drugs such as vaccines and monoclonal antibodies, and advent of biosimilars or generic biological drugs are driving production of these drugs.

Chromatography systems, centrifuges, and membranes/filters represent the most commonly used technologies for bioseparation. Chromatography especially is a popular technique used in downstream processing of biopharmaceuticals, where it remains the gold standard primarily in purification. The growth in the market will be spearheaded by Centrifuges, and Filters/Membranes. Membranes are increasingly being used in the development of pharmaceuticals, right from laboratory research to industrial production of drugs. The growing focus on cost efficiencies and the ensuing increase in demand for more efficient and optimized techniques in downstream processing of biopharmaceuticals are driving technology innovation in the market. Development of single-use/disposable technologies represents a major advancement in this area, conferring significant benefits to various stages of bioprocessing, including elimination of cleaning steps, minimizing cross-infection risks, improving flexibility and convenience, and expediting turnaround times. The trend is also spurred by the slew of new regulations and increasing focus on production efficiency and product quality. A key development driving growth in the market is the development of alternatives to Protein A based purification in affinity chromatography.

As stated by the new market research report on Biopharmaceutical Bioseparation Systems, the United States represents the largest market worldwide, supported by a well-established innovation-driven pharmaceutical industry, continuous development of new biologics, easing regulations on biosimilar drugs and a slew of biological drugs going off-patent. Asia-Pacific ranks as the fastest growing market with a CAGR of 12.8% over the analysis period, led by the strong focus of local governments on drug research, and developing medical and scientific research infrastructure.

Major players covered in the report include 3M Purification, Inc., Agilent Technologies, Inc., Alfa Wassermann Separation Technologies, LLC, Flottweg Separation Technology, GEA Westfalia Separator Group GmbH, GE Healthcare, KNAUER Wissenschaftliche Geräte GmbH, Konik Nanobiotech SL, Merck KGaA, NuSep Holdings Ltd., Pall Corporation, ProMetic Life Sciences, Inc., Sartorius Stedim Biotech, Spectrum Laboratories, Inc., Thermo Fisher Scientific, Inc., Tosoh Bioscience, Inc. and YMC Europe GMBH among others.

The research report titled “Biopharmaceutical Bioseparation Systems: A Global Strategic Business Report” announced by Global Industry Analysts Inc., provides a comprehensive review of market trends, issues, drivers, mergers, acquisitions and other strategic industry activities of global companies. The report provides market estimates and projections for Biopharmaceutical Bioseparation Systems in terms of US$ for all major geographic markets such as the US, Canada, Japan, Europe (France, Germany, Italy, UK, Spain, Russia and Rest of Europe) Asia-Pacific (China, India and Rest of Asia-Pacific), Middle East & Africa and Latin America (Brazil and Rest of Latin America). Global market for Biopharmaceutical Bioseparation Systems is also analyzed by the following product segments – Chromatography Systems and Other Systems (includes Centrifuges, and Filters/ Membranes).

Global Industry Analysts, Inc. 6150 Hellyer Ave., San Jose CA 95138, USA, All Rights Reserved.